 Source: Andrew Partheniou 122022 The company, focused on psychedelic-assisted psychotherapies to better treat addiction, is worth more than the CA10 million the market is valuing it at, noted a Stifel report. Awakn Life Sciences Corp. AWKN:NEO; AWKNF:OTCQB is currently undervalued and, thus, providing investors an attractive time to get into the stock, reported Stifel analyst Andrew ...... 